Verastem in Licensing Agreement with Sanofi; Shares Up

Date : 07/25/2019 @ 9:31PM
Source : Dow Jones News
Stock : Sanofi (SNY)
Quote : 46.52  -0.65 (-1.38%) @ 12:59AM
After Hours
Last Trade
Last $ 46.52 ◊ 0.00 (0.00%)

Verastem in Licensing Agreement with Sanofi; Shares Up

Verastem (NASDAQ:VSTM)
Historical Stock Chart

6 Months : From May 2019 to Nov 2019

Click Here for more Verastem Charts.

By Michael Dabaie


Verastem Inc. (VSTM) said Thursday it is in a licensing agreement with Sanofi (SNY).

The agreement is for biopharmaceutical company Verastem's Copiktra for the treatment of all oncology indications in Russia and CIS, Turkey, the Middle East and Africa.

Shares were up 7% after hours to $1.40.

Verastem will receive an upfront payment of $5 million and can receive up to an additional $42 million in development and sales milestone payments, plus double-digit percentage royalties. Sanofi will receive exclusive rights to develop and commercialize Copiktra, and hold the marketing authorization and product license for Copiktra, in the licensed territories.


Write to Michael Dabaie at


(END) Dow Jones Newswires

July 25, 2019 17:16 ET (21:16 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest SNY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.